Ann: Extension of MDR Share Purchase Plan, page-4

yes that question was asked on the 3q update & he indicated they already have contracts with all those pharmacies (what was less clear was how strongroom with a smaller footprint & having to get their products into the pharmacies had managed to generate 14m in recurring revenues when mdr should have been in a much better position having built up the relationship over many yrs.....although perhaps that 14m is not a good number given some of the allegations that are coming out).

i still cant see too much change in the chances to taise much money in the spp....no real change in sentiment in US (it seems they will back off tariffs etc, but vaccine hesitancy still there even with measles spreading) & company still not ebitda positive in fy25